Good publication practice for communicating company sponsored medical research: the GPP2 guidelines
The good publication practice (GPP2) guidelines make recommendations that will help individuals and organisations maintain ethical practices and comply with current requirements when they contribute to the communication of medical research sponsored by companies. These guidelines which were published in the BMJ apply to peer reviewed journal articles and presentations at scientific congresses.
In response to changes in the environment in which authors, presenters, and other contributors work together to communicate medical research the International Society for Medical Publication Professionals has updated the good publication practice guidelines
Authors and presenters are responsible for how medical research is interpreted and communicated. Often their work is the product of collaborations with other individuals (such as clinical investigators, biostatisticians, and professional medical writers) from around the world. Some or all of the people who contribute to this collaboration may be employees of research sponsors, contract research organisations, or medical communications agencies that may be funded by pharmaceutical, medical device, or biotechnology companies. The authors, collaborators, and organisations share responsibility for developing articles and presentations in a responsible and ethical manner.
